Showing results (31-40 of 94) with videos related to
Sort By:
Pageof 10
Annals of Translational Medicine|November 4, 2021
The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional studyFangyuan Tian, Shili Liao, Zhaoyan Chen, et al.Frontiers in Pharmacology|June 30, 2022
Potentially Inappropriate Medication Among People With Dementia in China: A Nationwide Cross-Sectional StudyMengnan Zhao, Zhaoyan Chen, Fangyuan Tian, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 20, 2025
Economic Evaluation of Deprescribing in Older Adults: A Systematic ReviewYing Zhang, Zhaoyan Chen, Xi Chen, et al.Journal of Global Health|February 6, 2025
Impact of Chinese criteria on potentially inappropriate medication use in ChinaFangyuan Tian, Zhaoyan Chen, Ying Zhang, et al.Frontiers in Pharmacology|September 11, 2023
Global prevalence of polypharmacy and potentially inappropriate medication in older patients with dementia: a systematic review and meta-analysisMengnan Zhao, Zhaoyan Chen, Ting Xu, et al.Journal of Geriatric Oncology|February 20, 2022
The prevalence and factors associated with potentially inappropriate medication use in Chinese older outpatients with cancer with multimorbidityFangyuan Tian, Ruonan Yang, Zhaoyan Chen, et al.Journal of Epidemiology and Global Health|March 12, 2025
Prevalence and Factors with Potentially Inappropriate Prescribing among Older Surgical Outpatients in China: A Nationwide Cross-sectional Study in 100 HospitalsFangyuan Tian, Zhaoyan Chen, Jinyuan Zhang, et al.JAMA Network Open|August 2, 2023
Prevalence of Use of Potentially Inappropriate Medications Among Older Adults Worldwide: A Systematic Review and Meta-AnalysisFangyuan Tian, Zhaoyan Chen, Ya Zeng, et al.Frontiers in Pharmacology|October 24, 2022
Impact of the expert consensus on polypharmacy and potentially inappropriate medication use in elderly lung cancer outpatients with multimorbidity: An interrupted time series analysis, 2016-2021Fangyuan Tian, Zhaoyan Chen, Rui Tang, et al.Plos One|April 29, 2020
Validating the Chinese geriatric trigger tool and analyzing adverse drug event associated risk factors in elderly Chinese patients: A retrospective reviewQiaozhi Hu, Zhou Qin, Mei Zhan, et al.Pageof 10